
    change to recommended season flu vaccine in uk
  
['influenza']
['seasonal influenza vaccine', 'mva-np+m1', 'sodium chloride']

        Inclusion Criteria:

          -  Volunteer is willing and has capacity to provide written informed consent for
             participation in the trial (in the Investigator's opinion).

          -  Male or female adults, aged 65 years and above

          -  Able and willing (in the Investigator's opinion) to comply with all study requirements

          -  Willing to allow the investigators to discuss the volunteer's medical history with
             their General Practitioner

          -  Eligible to receive seasonal influenza vaccine

        Exclusion Criteria:

          -  Any history of anaphylaxis in reaction to vaccination or history of allergic reactions
             likely to be exacerbated by any component of the vaccine (e.g. egg allergy)

          -  Ongoing terminal illness with a life expectancy estimated to be approximately <6
             months.

          -  Continuous use of oral anticoagulants, such as coumarins and related anticoagulants
             (i.e. warfarin) or novel oral anticoagulants (i.e. apixaban, rivaroxaban, dabigatran
             and edoxaban)

          -  Any other significant disease, disorder or finding (including blood test results),
             which, in the opinion of the Investigators, would either put the volunteer at risk
             because of participation in the study, or may influence the result of the study

          -  Participation in another clinical trial of an investigational medicinal product in the
             30 days preceding enrolment, or planned use during the study period

          -  Prior receipt of an investigational vaccine likely to impact on interpretation of the
             trial data

          -  Receipt of annual seasonal influenza vaccine prior to enrolment (for the same
             influenza season volunteers are recruited in)

          -  Not willing to comply with study procedures
      